The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Cellular and Molecular Immunology
Abbas, A. K., Lichtman, A. H., & Pillai, S. S. (1994) · Cited by 3,570
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Cellular and Molecular Immunology
Denman, A. M. (1992) · Postgraduate Medical Journal · doi:10.1136/pgmj.68.798.305 · Cited by 2,800
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., & Chen, Z. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00126-4 · Cited by 1,872
CD40 AND CD154 IN CELL-MEDIATED IMMUNITY
Grewal, I. S., & Flavell, R. A. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.111 · Cited by 1,539
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
Lomaga, M. A., Yeh, W.-C., Sarosi, I., Duncan, G. S., Furlonger, C., Ho, A., Morony, S., Capparelli, C., Van, G., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,267
Klein, U., Rajewsky, K., & Küppers, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.9.1679 · Cited by 1,154
Yamaoka, S., Courtois, G., Bessia, C., Whiteside, S. T., Weil, R., Agou, F., Kirk, H. E., Kay, R. J., & Israël, A. (1998) · Cell · doi:10.1016/s0092-8674(00)81466-x · Cited by 1,076
CD40 Ligand Gene Defects Responsible for X-Linked Hyper-IgM Syndrome
Allen, R. C., Armitage, R. J., Conley, M. E., Rosenblatt, H., Jenkins, N. A., Copeland, N. G., Bedell, M. A., Edelhoff, S., Disteche, C. M., Simoneaux, D. K., et al. (1993) · Science · doi:10.1126/science.7679801 · Cited by 830
Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti
The International Incontinentia Pigmenti (IP) Consortium (2000) · Nature · doi:10.1038/35013114 · Cited by 750
Kere, J., Srivastava, A. K., Montonen, O., Zonana, J., Thomas, N., Ferguson, B., Munoz, F., Morgan, D., Clarke, A., Baybayan, P., et al. (1996) · Nature Genetics · doi:10.1038/ng0895-409 · Cited by 749
Mice deficient for the CD40 ligand
Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J., Noelle, R. J., & Flavell, R. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90073-6 · Cited by 734
CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM
DiSanto, J. P., Bonnefoy, J. Y., Gauchatt, J. F., Fischer, A., & Saint Basile, G. D. (1993) · Nature · doi:10.1038/361541a0 · Cited by 704
Naito, A., Azuma, S., Tanaka, S., Miyazaki, T., Takaki, S., Takatsu, K., Nakao, K., Nakamura, K., Katsuki, M., Yamamoto, T., et al. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00265.x · Cited by 635
Humoral immune responses in CD40 ligand-deficient mice.
Renshaw, B. R., Fanslow, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., & Maliszewski, C. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1889 · Cited by 536
Zonana, J., Elder, M. E., Schneider, L. C., Orlow, S. J., Moss, C., Golabi, M., Shapira, S. K., Farndon, P. A., Wara, D. W., Emmal, S. A., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316914 · Cited by 521
Han, S., Hathcock, K., Zheng, B., Kepler, T. B., Hodes, R., & Kelsoe, G. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.2.556 · Cited by 480
Maniatis, T. (1999) · Genes & Development · doi:10.1101/gad.13.5.505 · Cited by 421
Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction
Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., & Delespesse, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250442 · Cited by 414
The IKK complex: an integrator of all signals that activate NF-κB?
Israël, A. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01729-3 · Cited by 398
Monreal, A. W., Ferguson, B. M., Headon, D. J., Street, S. L., Overbeek, P. A., & Zonana, J. (1999) · Nature Genetics · doi:10.1038/11937 · Cited by 397
Yan, M., Wang, L.-C., Hymowitz, S. G., Schilbach, S., Lee, J., Goddard, A., de Vos, A. M., Gao, W.-Q., & Dixit, V. M. (2000) · Science · doi:10.1126/science.290.5491.523 · Cited by 311
Immunodeficiency with hyper-IgM (HIM).
Notarangelo, L. D., Duse, M., & Ugazio, A. G. (1992) · PubMed · Cited by 308
Sutherland, C. L., Heath, A. W., Pelech, S. L., Young, P. R., & Gold, M. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3381 · Cited by 235
Kroczek, R. A., Graf, D., Brugnoni, D., Giliani, S., Korthäuer, U., Ugazio, A. G., Senger, G., Mages, H. W., VILLA, A. M., & Notarangelo, L. D. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00846.x · Cited by 124
Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome
Jain, A., Atkinson, T. P., Lipsky, P. E., Slater, J. E., Nelson, D. L., & Strober, W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5891 · Cited by 116
Self-citationGrammer, A. C., Swantek, J. L., McFarland, R., Miura, Y., Geppert, T. D., & Lipsky, P. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.3.1183 · Cited by 79
Isolation of full-length cDNA and chromosomal localization of human NF-κB modulator NEMO to Xq28
Jin, D., & Jeang, K. (1999) · Journal of Biomedical Science · doi:10.1007/bf02256442 · Cited by 62
[Immunodeficiency with hyper-IgM].
Sugai, S. (1998) · PubMed · Cited by 32
Cited by
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,111
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00312-6 · Cited by 2,135
Pyogenic Bacterial Infections in Humans with MyD88 Deficiency
von Bernuth, H., Picard, C., Jin, Z., Pankla, R., Xiao, H., Ku, C.-L., Chrabieh, M., Mustapha, I. B., Ghandil, P., Camcioglu, Y., et al. (2008) · Science · doi:10.1126/science.1158298 · Cited by 1,287
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
The IKK Complex, a Central Regulator of NF- B Activation
Israel, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000158 · Cited by 849
Metadata
- Authors
- Jain, A., Ma, C. A., Liu, S., Brown, M., Cohen, J., & Strober, W.
- Venue
- Nature Immunology
- Published
- 2001-03
- Volume
- 2
- Issue
- 3
- Pages
- 223-228
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W1502772682
- Cited by
- 392
- References
- 31
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.